ImmunityBio (IBRX) Goodwill (2024 - 2026)
ImmunityBio (IBRX) posted quarterly Goodwill of $910000.0 for Q1 2026, little changed year-over-year from $910000.0 in Q1 2025, and little changed quarter-over-quarter from $910000.0 in Q4 2025.
Analysis
ImmunityBio (IBRX) Goodwill (2024 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Goodwill for 3 consecutive years, with $910000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill changed 0.0% year-over-year to $910000.0; the TTM figure through Mar 2026 stood at $910000.0 (changed 0.0% YoY), while the FY2025 annual figure was $910000.0, changed 0.0% from the prior year.
- Goodwill held at $910000.0 in Q1 2026 per IBRX's latest filing, from $910000.0 in the prior quarter.
- Across five years, Goodwill topped out at $910000.0 in Q4 2024 and bottomed at $900000.0 in Q3 2024.
- Historically, Goodwill has averaged $908571.4 across 3 years, with a median of $910000.0 in 2024.
- On a YoY basis, Goodwill climbed as much as 1.11% in 2025 and fell as far as 0.0% in 2025.
- ImmunityBio's Goodwill stood at $910000.0 in 2024, then changed by 0.0% to $910000.0 in 2025, then changed by 0.0% to $910000.0 in 2026.
- Business Quant data shows IBRX's Goodwill at $910000.0 in Q1 2026, $910000.0 in Q4 2025, and $910000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | ImmunityBio | 8.51 Bn | 8.15 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 910,000.00 |
| Dec 31, 2025 | 910,000.00 |
| Sep 30, 2025 | 910,000.00 |
| Jun 30, 2025 | 910,000.00 |
| Mar 31, 2025 | 910,000.00 |
| Dec 31, 2024 | 910,000.00 |
| Sep 30, 2024 | 910,000.00 |